Clinical Trial Center of Asan Medical Center (Ver. English)

Clinical trials;
Which country will you choose to conduct clinical trials?

The answer is, the Republic of Korea.

Korea is one of the rapidly growing
countries in the global trial market.

Among Asian countries,
Korea is the country which hosted the most clinical trials

Korea has grown into a global clinical trial leader
along with global pharmaceutical companies and CROs.

The population of Korea is approximately 52,000,000
and 50% of the population resides in metropolitan areas.
Owing to the high educational level of its citizens,
we have an extremely high conscious status on medical care and treatment.

Korea has a national health insurance system which covers nearly 100% of population.
The Korean government is a single payer for the health care insurance and accountable for it.
This fact helps positively for clinical research.

Since medical expenses are not a burden to individuals,
health care services are very accessible.

Furthermore, patients are free to choose which clinic or hospital to get medical treatment.

Thanks to the geographical features and convenient transportation infrastructure,
Nearly 70% of the whole Korean population can access Asan Medical Center within 2 hours.
From anywhere in Korea, within a few hours..

As a single institution, Asan Medical Center has the largest medical infrastructure in Korea
with matchless treatment performances.
Based on the outstanding clinical researches by the top-level medical teams,
Asan Medical Center is very strong in organ transplantation and cancer surgeries
as well as the field of incurable diseases.
In addition, we are part of the development of global medical science standards
through cooperation with overseas organizations for clinical practices and R&D.

The Clinical Trial Center in Asan Medical Center
conducts clinical trials with optimized operational processes and specialized functional teams.

ASAN CRDW is the first clinical trial IT infrastructure in Korea
that allows to search and identify necessary medical information quickly and accurately
even for a complicated study protocol. With CTMS, its management efficiency has greatly enhanced.

With an optimized clinical trial process ~!

The Institutional Review Board accepts English protocol for phase 1 clinical trials the first time in Korea, and there are 9 regular reviews per month, making it an efficient and quick process.

From the initial step for a clinical trial to subject enrollment and study close out step,
Asan CTC is trying to support optimized processes.
For example, a Study Start-up team has been set up to effectively reduce the timeline for start-up stage.

Also, if a study subject visit an emergency room due to SAE,
this event will be immediately notified to the responsible investigators via mobile text so that the SAE will be promptly and properly managed .

Qualified staff are assigned to conduct a clinic trial for improved efficiency and expertise.

Asan CTC has a Phase 1 clinical trial unit for healthy volunteers and also for patients. Clinical operation team is organized to conduct customized clinical trials on various diseases.

A full scope of services for clinical trial is offered by clinical pharmacology department, PK lab, pharmacy, and clinical research data management team.

Thanks to the optimized operational processes and expertise, Asan Medical Center is one of the centers that have conducted the highest number of early phase clinical trials in Korea, which is well recognized in Korea.

Quite a number of study coordinators in Asan CTC has international certificate such as SOCRA, and to ensure the quality of clinical trials, Asan has its own internal audit team.

Also, external audits from various sponsors and inspections not only from Korean-FDA but also US, EU and Japan demonstrated its high level of quality in conducting clinical trials in Asan Medical Center.

Based on its high quality of clinical trials, advanced infrastructure and research capacities,
Asan Medical Center is building partnership with more and more global pharmaceutical companies
and CROs and these will lead to further noticeable performances.

Asan Medical Center will try its best to become a truly global center of excellence in clinical trial covering from early studies to later stage of studies in various therapeutic areas with its rich experiences in clinical research, excellent investigators, and advanced infrastructure.